SC

SilverArc Capital

North America, Massachusetts, United States, Boston

Description

SilverArc Capital is an investment firm.

Investor Profile

SilverArc Capital has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in United States, Israel, Germany.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Post Ipo Equity (63%)
  • Series A (25%)
  • Series C (13%)

Country Focus

  • United States (63%)
  • Israel (13%)
  • Germany (13%)
  • Canada (13%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Agriculture
  • Genetics
  • Artificial Intelligence (Ai)
  • Enterprise Software
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SilverArc Capital frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 2
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 3
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 2
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 2
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Avidity Partners
North America, Texas, United States, Dallas
Co-Investments: 1
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 2
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Armistice Capital
North America, New York, United States, New York
Co-Investments: 3
Walleye Capital
North America, Minnesota, United States, Plymouth
Co-Investments: 2

Which angels does SilverArc Capital often collaborate with?

JK
North America, Massachusetts, United States, Boston
Shared Deals: 1
PS
North America, California, United States, Sunnyvale
Shared Deals: 1
BP
North America, Washington, United States, Auburn
Shared Deals: 1
AK
North America, California, United States, Mountain View
Shared Deals: 1
SF
North America, Massachusetts, United States, Boston
Shared Deals: 1
SJ
North America, California, United States, Los Angeles
Shared Deals: 1
EJ
North America, Utah, United States, Salt Lake City
Shared Deals: 1
AB
North America, Massachusetts, United States, Boston
Shared Deals: 1
GS
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by SilverArc Capital?

CORXEL Pharmaceuticals

Shanghai, Shanghai, China

CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.

BiotechnologyHealth CareMedical
Series DJan 22, 2026
Amount Raised: $287,000,000
Manifold

Newton, Massachusetts, United States

Manifold offers machine learning tools for analyzing operational data and supporting decision making in industrial and energy use cases.

Artificial Intelligence (AI)Enterprise SoftwareHealth CareLife ScienceSoftware
Series BDec 18, 2025
Amount Raised: $18,000,000
Modulight Bio

Boston, Massachusetts, United States

Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.

BiotechnologyHealth CareMedicalTherapeutics
SeedNov 13, 2025
Amount Raised: $12,000,000
Congruence Therapeutics

Montréal, Quebec, Canada

Congruence Therapeutics operates as a biotechnology company.

BiotechnologyMedical
Series UnknownSep 4, 2025
Amount Raised: $32,000,000
Aardvark Therapeutics

San Diego, California, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series CMay 9, 2024
Amount Raised: $85,000,000
Unicycive Therapeutics

Los Altos, California, United States

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

BiotechnologyHealth CareHealth DiagnosticsMedical
Post Ipo EquityMar 14, 2024
Amount Raised: $50,000,000
Manifold

Newton, Massachusetts, United States

Manifold is an AI-powered clinical research platform.

Artificial Intelligence (AI)Enterprise SoftwareHealth CareLife ScienceSoftware
Series ANov 14, 2023
Amount Raised: $15,000,000
Gossamer Bio

San Diego, California, United States

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJul 20, 2023
Amount Raised: $212,000,000
Evogene

Rehovot, HaMerkaz, Israel

Evogene is a biotechnology company developing novel products for life science markets through the use of a unique CPB platform.

AgricultureBiotechnologyGenetics
Post Ipo EquityJul 17, 2023
Amount Raised: $8,500,000
Congruence Therapeutics

Montréal, Quebec, Canada

Congruence Therapeutics operates as a biotechnology company.

BiotechnologyMedical
Series AMar 6, 2023
Amount Raised: $15,000,000

Find More Investors Like SilverArc Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

SilverArc Capital | Pipeseed